AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26346932 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention (after adjustment for confounding factors).
Number of subjects: 705
Study 26346932 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal intervention (univariate analysis).
Number of subjects: 705
Study 23695914 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback-based (FB) instruction
Number of subjects: 26
Study 23695914 — intervention group
Group type: EXPERIMENTAL
Intervention: Paired-associate (PA) instruction
Number of subjects: 26
Study 23695914 — intervention group
Group type: EXPERIMENTAL
Intervention: Typical training condition
Number of subjects: 26
Study 23695914 — intervention group
Group type: EXPERIMENTAL
Intervention: Atypical training condition
Number of subjects: 26
Study 23695914 — intervention group
Group type: COMPARATOR
Intervention: Nonaphasic controls
Number of subjects: 26
Study 21775973 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent nocturnal hemodialysis (6 times per week)
Number of subjects: 87
Study 21775973 — intervention group
Group type: COMPARATOR
Intervention: Conventional hemodialysis (3 times per week)
Number of subjects: 87
Study 19435763 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample size calculation reporting
Number of subjects: 215
Study 19435763 — intervention group
Group type: EXPERIMENTAL
Intervention: Sample size calculation accuracy
Number of subjects: 215
Study 19435763 — intervention group
Group type: COMPARATOR
Intervention: Assumptions for control group
Number of subjects: 215
Study 19435763 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall reporting quality
Number of subjects: 215
Study 17152087 — intervention group
Group type: EXPERIMENTAL
Intervention: Simultaneous bilateral DCE-MRI with high frame-rate and 16x acceleration factor over conventional MR scans.
Number of subjects: 54
Study 15061259 — intervention group
Group type: EXPERIMENTAL
Intervention: FDG PET imaging
Number of subjects: 10
Study 11213884 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg once daily
Number of subjects: 959
Study 11213884 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 2 mg twice daily
Number of subjects: 959
Study 11213884 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 8 mg once daily
Number of subjects: 959
Study 11213884 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg twice daily
Number of subjects: 959
Study 11213884 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 959
Study 11213884 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone (all doses)
Number of subjects: 959
Study 9609364 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical excision, debridement, and surgical closure (Group B)
Number of subjects: 42
Study 9609364 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment (Group A)
Number of subjects: 42
Study 7914307 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 U/kg rhEPO subcutaneously twice a week for 3 weeks
Number of subjects: 95
Study 7914307 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 95
Study 2885878 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine (average dose 1240 mg/day, blood levels 10.4 +/- 2.2 micrograms/ml)
Number of subjects: 19
Study 2885878 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbamazepine responders (12 patients)
Number of subjects: 19
Study 2885878 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative family history of affective illness (7 patients)
Number of subjects: 19
Study 2885878 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive family history of affective illness
Number of subjects: 19
Study 2885878 — intervention group
Group type: COMPARATOR
Intervention: Nonresponders (7 patients)
Number of subjects: 19
Study 30015503 — intervention group
Group type: EXPERIMENTAL
Intervention: Stories intervention (n=23, 5 women and 18 men)
Number of subjects: 71
Study 30015503 — intervention group
Group type: COMPARATOR
Intervention: Cognitive treatment control (n=24, 8 women and 16 men)
Number of subjects: 71
Study 28372563 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS programme
Number of subjects: 0
Study 28372563 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 0
Study 26277100 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured interventional harmonisation process
Number of subjects: 11
Study 26277100 — intervention group
Group type: COMPARATOR
Intervention: Baseline inter-observer agreement assessment
Number of subjects: 11
Study 26277100 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved reading criteria
Number of subjects: 11
Study 23142494 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate
Number of subjects: 140
Study 23142494 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 16825032 — intervention group
Group type: EXPERIMENTAL
Intervention: American Heart Association Step II diet
Number of subjects: 0
Study 16825032 — intervention group
Group type: COMPARATOR
Intervention: Mediterranean diet
Number of subjects: 0
Study 12811707 — intervention group
Group type: EXPERIMENTAL
Intervention: Eutectic mixture of local anesthetics
Number of subjects: 40
Study 12811707 — intervention group
Group type: EXPERIMENTAL
Intervention: VAS-based pain comparisons for jellyfish stings
Number of subjects: 40
Study 12811707 — intervention group
Group type: COMPARATOR
Intervention: Serial 20- to 30-minute pain comparisons
Number of subjects: 40
Study 10330942 — intervention group
Group type: EXPERIMENTAL
Intervention: Drainage (n = 248) with 2 multiperforated 14F suction drains
Number of subjects: 494
Study 10330942 — intervention group
Group type: COMPARATOR
Intervention: No drainage (n = 246)
Number of subjects: 494
Study 10330942 — intervention group
Group type: EXPERIMENTAL
Intervention: Drainage (n = 248)
Number of subjects: 494
Study 7560400 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth disinfection with removal of all plaque and calculus in two visits within 24 hours, tongue brushed with 1% chlorhexidine gel, mouth rinsed with 0.2% chlorhexidine solution, subgingival chlorhexidine (1%) irrigation performed in all pockets
Number of subjects: 10
Study 7560400 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-mouth disinfection
Number of subjects: 10
Study 7560400 — intervention group
Group type: COMPARATOR
Intervention: Control group received scalings and root planings per quadrant at two-week intervals
Number of subjects: 10
Study 1767639 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional splint
Number of subjects: 63
Study 1767639 — intervention group
Group type: COMPARATOR
Intervention: Plaster cast immobilization
Number of subjects: 63
Study 7102585 — intervention group
Group type: COMPARATOR
Intervention: Control diet (80 mEq K+/day)
Number of subjects: 8
Study 7102585 — intervention group
Group type: EXPERIMENTAL
Intervention: Low K+ diet (25 mEq K+/day)
Number of subjects: 8
Study 31271654 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized feedback report and stage-matched brochure
Number of subjects: 79
Study 31271654 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention details provided)
Number of subjects: 79
Study 28816734 — intervention group
Group type: EXPERIMENTAL
Intervention: Active rest program (short-time exercise) for 10 minutes per day, 3-4 times per week for 8 weeks
Number of subjects: 130
Study 28816734 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 130
Study 26472130 — intervention group
Group type: EXPERIMENTAL
Intervention: Pay for performance (P4P) strategy with quarterly incentive payments based on seven performance indicators.
Number of subjects: 11953
Study 26472130 — intervention group
Group type: COMPARATOR
Intervention: Control group (comparison arm)
Number of subjects: 11953
Study 24138688 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination beclometasone/formoterol hydrofluoroalkane (HFA)‐MDI used as both maintenance and reliever therapy
Number of subjects: 0
Study 24138688 — intervention group
Group type: COMPARATOR
Intervention: Fixed dose of maintenance beclometasone/formoterol HFA‐MDI with salbutamol MDI for relief
Number of subjects: 0
Study 21784838 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 300 mg/d
Number of subjects: 30
Study 21784838 — intervention group
Group type: COMPARATOR
Intervention: Control hyperuricemic group
Number of subjects: 30
Study 21784838 — intervention group
Group type: COMPARATOR
Intervention: Normouricemic group
Number of subjects: 30
Study 19792858 — intervention group
Group type: EXPERIMENTAL
Intervention: Polydioxanone (PDS) tent without a guided tissue regeneration (GTR) membrane
Number of subjects: 16
Study 16766419 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine gum (4 mg)
Number of subjects: 14
Study 16766419 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 14
Study 15234403 — intervention group
Group type: EXPERIMENTAL
Intervention: Reperfusion therapy for acute STEMI
Number of subjects: 5470
Study 11236835 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent treatment for both alcohol and social anxiety problems (n = 49)
Number of subjects: 93
Study 11236835 — intervention group
Group type: COMPARATOR
Intervention: Individual cognitive behavioral therapy for alcoholism only (n = 44)
Number of subjects: 93
Study 9007742 — intervention group
Group type: EXPERIMENTAL
Intervention: Blink reflex (BR) response to supraorbital nerve electrical stimuli
Number of subjects: 20
Study 9007742 — intervention group
Group type: EXPERIMENTAL
Intervention: Late responses elicited on the side of the lesion by stimulation of the non-affected supraorbital nerve
Number of subjects: 20
Study 9007742 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall BR pattern
Number of subjects: 20
Study 8317644 — intervention group
Group type: EXPERIMENTAL
Intervention: Pethidine 100 mg added to 40 ml prilocaine 0.25%
Number of subjects: 0
Study 3816105 — intervention group
Group type: EXPERIMENTAL
Intervention: Analog computer
Number of subjects: 54
Study 3816105 — intervention group
Group type: EXPERIMENTAL
Intervention: Linear regression
Number of subjects: 54
Study 3816105 — intervention group
Group type: EXPERIMENTAL
Intervention: Empiric dosing
Number of subjects: 54
Study 3816105 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 54
Study 29405762 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot herbal compress
Number of subjects: 0
Study 29405762 — intervention group
Group type: EXPERIMENTAL
Intervention: Hot compress
Number of subjects: 0
Study 29405762 — intervention group
Group type: COMPARATOR
Intervention: Topical diclofenac
Number of subjects: 0
Study 26610367 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 24597550 — intervention group
Group type: EXPERIMENTAL
Intervention: NMES
Number of subjects: 12
Study 24597550 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 12
Study 23702987 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote patient management (RPM)
Number of subjects: 288
Study 19481278 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol-first
Number of subjects: 40
Study 19481278 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril-first
Number of subjects: 40
Study 18166191 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose B-vitamin therapy
Number of subjects: 2124
Study 16864642 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebronchodilator FEV1% > or = 100%
Number of subjects: 417
Study 16864642 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebronchodilator FEV1% 60% to 79%
Number of subjects: 417
Study 16864642 — intervention group
Group type: EXPERIMENTAL
Intervention: Prebronchodilator FEV1% < 60%
Number of subjects: 417
Study 16864642 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean symptom score (0-3)
Number of subjects: 417
Study 16864642 — intervention group
Group type: EXPERIMENTAL
Intervention: Asthma-related events (oral steroid use, emergency department visits, hospitalizations)
Number of subjects: 417
Study 14650098 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG administered orally in yogurt base (10^9 CFU) for 1 month, 1 or 2 doses per day
Number of subjects: 42
Study 10894268 — intervention group
Group type: EXPERIMENTAL
Intervention: GART group (genotypic antiretroviral resistance testing)
Number of subjects: 153
Study 10894268 — intervention group
Group type: COMPARATOR
Intervention: No-GART group (no genotypic antiretroviral resistance testing)
Number of subjects: 153
Study 8792320 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual muscle testing while viewing a threat stimulus (cue word on a printed card)
Number of subjects: 27
Study 8792320 — intervention group
Group type: COMPARATOR
Intervention: Control group (nonphobic subjects)
Number of subjects: 27
Study 1638713 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg captopril
Number of subjects: 10
Study 1638713 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg captopril
Number of subjects: 10
Study 1638713 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 6395280 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefonicid 1 g intravenously or intramuscularly 1 hr before surgery
Number of subjects: 57
Study 6395280 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin 2 g intravenously or intramuscularly 1 hr before surgery and 2 g every 6 hr for 24 hr
Number of subjects: 57
Study 30536570 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D printed simulator
Number of subjects: 35
Study 30536570 — intervention group
Group type: COMPARATOR
Intervention: Traditional didactic learning
Number of subjects: 35
Study 30200582 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey Protein (WP, 77 g/day protein, 580 kcal/day)
Number of subjects: 69
Study 30200582 — intervention group
Group type: EXPERIMENTAL
Intervention: Whey Protein (WP)
Number of subjects: 69
Study 30200582 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate (CHO, 127 g/day carbohydrate, 580 kcal/day)
Number of subjects: 69
Study 30200582 — intervention group
Group type: COMPARATOR
Intervention: Carbohydrate (CHO)
Number of subjects: 69
Study 26792906 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week community program implemented by trained volunteers
Number of subjects: 185
Study 25734298 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic suppurative otitis media (CSOM) patients
Number of subjects: 390
Study 25734298 — intervention group
Group type: EXPERIMENTAL
Intervention: Computed tomography (CT) of the temporal bones in patients with CSOM and mucositis
Number of subjects: 390
Study 22130869 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine (60 mg)
Number of subjects: 24
Study 22130869 — intervention group
Group type: EXPERIMENTAL
Intervention: Olopatadine (5 mg)
Number of subjects: 24
Study 22130869 — intervention group
Group type: EXPERIMENTAL
Intervention: Promethazine (25 mg)
Number of subjects: 24
Study 22130869 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 20659611 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion of phenylephrine at 0.15 microg.kg(‐1).min(‐1) after spinal block
Number of subjects: 120
Study 20659611 — intervention group
Group type: EXPERIMENTAL
Intervention: Single dose of prophylactic phenylephrine 50 microg after spinal block
Number of subjects: 120
Study 20659611 — intervention group
Group type: COMPARATOR
Intervention: Single dose of phenylephrine 50 microg in case of hypotension
Number of subjects: 120
Study 17882915 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg pseudoephedrine (PSE) four times daily
Number of subjects: 216
Study 17882915 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 14996592 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 weeks of endurance exercise training
Number of subjects: 0
Study 12360468 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon alpha‐2b plus ribavirin
Number of subjects: 1521
Study 12360468 — intervention group
Group type: EXPERIMENTAL
Intervention: Peginterferon alpha‐2b plus ribavirin
Number of subjects: 1521
Study 10094742 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional hernia repair (Shouldice)
Number of subjects: 30
Study 10094742 — intervention group
Group type: COMPARATOR
Intervention: Endoscopic hernia repair (TEPP)
Number of subjects: 30
Study 7549843 — intervention group
Group type: EXPERIMENTAL
Intervention: Cryopreserved marrow cells using a mixture of 5% DMSO, 6% HES, and 4% Albumin in Lactated Ringer solution.
Number of subjects: 12
Study 7549843 — intervention group
Group type: COMPARATOR
Intervention: Cryopreserved marrow cells using 10% DMSO (control group).
Number of subjects: 12
Study 2379568 — intervention group
Group type: EXPERIMENTAL
Intervention: Reproductive health consultation
Number of subjects: 100
Study 2379568 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 80525 — intervention group
Group type: EXPERIMENTAL
Intervention: Tienilic acid (mean dose 210 mg)
Number of subjects: 36
Study 80525 — intervention group
Group type: COMPARATOR
Intervention: Cyclopenthiazide (mean dose 0.41 mg)
Number of subjects: 36
Study 80525 — intervention group
Group type: EXPERIMENTAL
Intervention: Tienilic acid
Number of subjects: 36
Study 80525 — intervention group
Group type: COMPARATOR
Intervention: Cyclopenthiazide
Number of subjects: 36
Study 80525 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 36
Study 29446160 — intervention group
Group type: EXPERIMENTAL
Intervention: SPF30 daily skin cream
Number of subjects: 17
Study 29446160 — intervention group
Group type: COMPARATOR
Intervention: Non-treated lentigines
Number of subjects: 17
Study 27689591 — intervention group
Group type: EXPERIMENTAL
Intervention: Background music with lyrics
Number of subjects: 65
Study 27689591 — intervention group
Group type: EXPERIMENTAL
Intervention: Background music that implies feeling 'loved'
Number of subjects: 65
Study 27689591 — intervention group
Group type: EXPERIMENTAL
Intervention: Music that makes listeners feel sad
Number of subjects: 65
Study 24736770 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Load (LL: 5% BM)
Number of subjects: 19
Study 24736770 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium Load (ML: 12.5% BM)
Number of subjects: 19
Study 24736770 — intervention group
Group type: EXPERIMENTAL
Intervention: High Load (HL: 20% BM)
Number of subjects: 19
Study 24159176 — intervention group
Group type: COMPARATOR
Intervention: Germline and somatic variations of TNFAIP3
Number of subjects: 574
Study 24159176 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional abnormalities of A20
Number of subjects: 574
Study 20812851 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐γ responses to Ag85
Number of subjects: 979
Study 20812851 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐γ responses to ESAT‐6
Number of subjects: 979
Study 20812851 — intervention group
Group type: EXPERIMENTAL
Intervention: IFN‐γ responses to WCL
Number of subjects: 979
Study 20812851 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline LPA responses
Number of subjects: 979
Study 18388901 — intervention group
Group type: EXPERIMENTAL
Intervention: Added Support (AS)
Number of subjects: 42
Study 18388901 — intervention group
Group type: COMPARATOR
Intervention: Standard Support (SS)
Number of subjects: 42
Study 17600973 — intervention group
Group type: EXPERIMENTAL
Intervention: Carraguard gel
Number of subjects: 200
Study 17600973 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly visit schedule preference
Number of subjects: 200
Study 17600973 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to use product
Number of subjects: 200
Study 17600973 — intervention group
Group type: EXPERIMENTAL
Intervention: Product use over time
Number of subjects: 200
Study 17600973 — intervention group
Group type: EXPERIMENTAL
Intervention: Trial design flexibility
Number of subjects: 200
Study 17600973 — intervention group
Group type: COMPARATOR
Intervention: Condoms-only arm
Number of subjects: 200
Study 11158407 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous venovenous haemofiltration (CVVH)
Number of subjects: 30
Study 11158407 — intervention group
Group type: COMPARATOR
Intervention: Intermittent haemodialysis (IHD)
Number of subjects: 30
Study 9921701 — intervention group
Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 623
Study 9921701 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 623
Study 8117177 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronized fenofibrate (200 mg daily)
Number of subjects: 60
Study 8117177 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg daily)
Number of subjects: 60
Study 8117177 — intervention group
Group type: COMPARATOR
Intervention: Switching from fenofibrate to simvastatin
Number of subjects: 60
Study 2455414 — intervention group
Group type: EXPERIMENTAL
Intervention: Etretinate + PUVA treatment
Number of subjects: 0
Study 2455414 — intervention group
Group type: COMPARATOR
Intervention: Etretinate monotherapy
Number of subjects: 0
Study 2455414 — intervention group
Group type: COMPARATOR
Intervention: Etretinate treatment (control side)
Number of subjects: 0
Study 2071980 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidrug therapy (MDT) for paucibacillary leprosy
Number of subjects: 54
Study 2071980 — intervention group
Group type: COMPARATOR
Intervention: Dapsone (DDS) monotherapy
Number of subjects: 54
Study 40572 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg temazepam with alcohol
Number of subjects: 18
Study 40572 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg temazepam with alcohol
Number of subjects: 18
Study 40572 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg temazepam with alcohol
Number of subjects: 18
Study 40572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 30346855 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Hydroxymethylfurfural and Alpha-Ketoglutaric Acid (5-HMF/α-KG)
Number of subjects: 17
Study 30346855 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 30699425 — intervention group
Group type: EXPERIMENTAL
Intervention: Early total enteral feeding (ETEF)
Number of subjects: 180
Study 30699425 — intervention group
Group type: COMPARATOR
Intervention: Conventional enteral feeding (CEF)
Number of subjects: 180
Study 28219107 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training (RT) for 12 weeks
Number of subjects: 35
Study 28219107 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) - no physical exercise
Number of subjects: 35